TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Código de la empresaTMDX
Nombre de la empresaTransmedics Group Inc
Fecha de salida a bolsaMay 02, 2019
Fundada en2018
Director ejecutivoDr. Waleed H. Hassanein, M.D.
Número de empleados728
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 02
Dirección200 Minuteman Road
CiudadANDOVER
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal01810
Teléfono19785520900
Sitio Webhttps://www.transmedics.com/
Código de la empresaTMDX
Fecha de salida a bolsaMay 02, 2019
Fundada en2018
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos